目录产品 » 抗体产品 » 一抗 » 抗独特型(Anti-idiotype)抗体 » Anti-Cetuximab Antibody (20H1), mAb, Mouse
Anti-Cetuximab Antibody (20H1), MAb, Mouse

Anti-Cetuximab Antibody (20H1), mAb, Mouse (GenScript, A01939-40) binds with Cetuximab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
Coating antigen: Cetuximab, 1 µg/ml.
Anti-Cetuximab antibody (GenScript, A01939-40) dilution start from 1,000 ng/ml.
EC₅₀= 4.803 ng/ml.

Anti-Cetuximab Antibody (20H1), MAb, Mouse

Standard curve of Cetuximab Sandwich ELISA. The Cetuximab Sandwich ELISA assay is developed by using Anti-Cetuximab Antibody (20H1), mAb, Mouse (GenScript, A01939-40) and Anti-Cetuximab Antibody (18D5), mAb, Mouse (GenScript, A01938-40) as capture and detection antibody, respectively.
In this ELISA assay, Anti-Cetuximab Antibody (18D5), mAb, Mouse (GenScript, A01938-40) was labeled with Biotin. GenScript can provide customized conjugation service for this product per customer's request. The sensitivity of detecting Cetuximab is 0.039 ng/ml.

Anti-Cetuximab Antibody (20H1), mAb, Mouse

The product is specific for Cetuximab. This antibody can’t block Cetuximab binding with EGFR (Z03202, EGFR, His, Human) in ELISA. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01938-40, Anti-Cetuximab Antibody (18D5), mAb, Mouse.
A01939
¥990

联系我们
Specificity The product is specific for Cetuximab. This antibody can’t block Cetuximab binding with EGFR (Z03202, EGFR, His, Human) in ELISA. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01938-40, Anti-Cetuximab Antibody (18D5), mAb, Mouse.
Host Species Mouse
Immunogen Cetuximab
Conjugate Unconjugated

Working concentrations for specific applications should be determined by the investigators. The appropriate concentration may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
ELISA 0.005-0.1 µg/ml

Form Lyophilized
Storage Buffer lyophilized with PBS, pH 7.4, contains 0.02% sodium azide.
Reconstitution Reconstitute the lyophilized powder with deionized water (or equivalent) to an final concentration of 0.5 mg/mL.
Storage Instructions The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid freeze/thaw cycles.
Purification Protein A affinity column
Isotype Mouse IgG2b,κ
Clonality Monoclonal
Clone ID 20H1
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

  • Anti-Cetuximab Antibody (20H1), MAb, Mouse
  • Anti-Cetuximab Antibody (20H1), MAb, Mouse

    Anti-Cetuximab Antibody (20H1), mAb, Mouse (GenScript, A01939-40) binds with Cetuximab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
    Coating antigen: Cetuximab, 1 µg/ml.
    Anti-Cetuximab antibody (GenScript, A01939-40) dilution start from 1,000 ng/ml.
    EC₅₀= 4.803 ng/ml.

  • Anti-Cetuximab Antibody (20H1), MAb, Mouse
  • Anti-Cetuximab Antibody (20H1), MAb, Mouse

    Standard curve of Cetuximab Sandwich ELISA. The Cetuximab Sandwich ELISA assay is developed by using Anti-Cetuximab Antibody (20H1), mAb, Mouse (GenScript, A01939-40) and Anti-Cetuximab Antibody (18D5), mAb, Mouse (GenScript, A01938-40) as capture and detection antibody, respectively.
    In this ELISA assay, Anti-Cetuximab Antibody (18D5), mAb, Mouse (GenScript, A01938-40) was labeled with Biotin. GenScript can provide customized conjugation service for this product per customer's request. The sensitivity of detecting Cetuximab is 0.039 ng/ml.


Target Background Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab, as an epidermal growth factor receptor (EGFR) inhibitor, binds to EGFR.
Synonyms Mouse monoclonal to Erbitux

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*